Search

for
Search:

GlossaryLenalidomide

medication used to treat specific blood cancers by modulating immunity

Lenalidomide is a medication primarily used to treat certain types of blood cancers, such as multiple myeloma and myelodysplastic syndromes. It works by modulating the immune system and inhibiting the growth of cancer cells. While it can be highly effective, it also has potential side effects, including an increased risk of blood clots and low blood cell counts.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 70 results

research Hair Repigmentation Associated with the Use of Lenalidomide: Graying May Not Be an Irreversible Process

25 citations , March 2012 in “Journal of oncology pharmacy practice”

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Cutaneous Adverse Reactions Linked to Targeted Anticancer Therapies Bortezomib and Lenalidomide for Multiple Myeloma: New Drugs, Old Side Effects

research Cutaneous Adverse Reactions Linked to Targeted Anticancer Therapies Bortezomib and Lenalidomide for Multiple Myeloma: New Drugs, Old Side Effects

18 citations , May 2013 in “Cutaneous and Ocular Toxicology”

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

research Lenalidomide for Refractory Cutaneous Manifestations of Pediatric Systemic Lupus Erythematosus

14 citations , November 2016 in “Lupus”

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

research Lenalidomide Augments Differentiation of Cultured Hair Follicle Derived Melanocyte Stem Cells Into Functional Melanocytes

April 2023 in “Dermatology practical & conceptual”

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

research Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist

11 citations , September 2022 in “The Journal of Rheumatology”

Skin problems are common in lupus patients and should be treated early to prevent worsening.

View more "lenalidomide" in research →

Community Join

0 / 0 results

— no results